Examples of using Development study in English and their translations into Romanian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
The Adolescent Brain Cognitive Development Study.
A pre- and postnatal development study was performed in rats.
Sofosbuvir had no adverse effects on behaviour,reproduction, or development of the offspring in the rat pre- and post-natal development study.
Data from a mouse fertility and early embryonic development study were not conclusive.
In a pre-/ postnatal development study performed in rats sitagliptin showed no adverse effects.
Plan drawing, building design, development study.
In a pre-/postnatal development study performed in rats sitagliptin showed no adverse effects.
Velpatasvir had no adverse effects on behaviour, reproduction, ordevelopment of the offspring in the rat pre- and post-natal development study at AUC exposures approximately 5-fold higher than the human exposure at the recommended clinical dose.
In the rat embryo-fetal development study dilatation of lateral ventricles of the brain was observed in the high dose group.
In a rat pre- and postnatal development study, the no observed effect dose was 30 mg/ kg/ day.
An embryofetal development study in pregnant rats did not indicate a teratogenic effect attributed to the co-administration of linagliptin and metformin at AUC exposure levels up to 4 and 30 times human exposure.
The data available from a rat embrofetal development study, where animals were given sodium aminosalicylate(3.85 to 385 mg/kg) were limited.
In a pre- and postnatal development study in rats, increased stillbirth and postnatal mortality, and decreased growth and physical development, were observed in the offspring of females treated with doses of≥7 mg/kg/day that did not elicit maternal toxicity.
In the rat, no adverse effects were observed in a pre- and post-natal development study at maternal plasma exposure(AUC) similar to humans and exposure in the offspring 3-fold higher than in adult humans.
The embryofetal development study in rats does not indicate direct or indirect harmful effects with respect to reproductive toxicity.
In the rat pre-/post-natal development study, selexipag induced no effects on maternal and pup reproductive function.
In a pre- and postnatal development study with abatacept in rats, no undesirable effects were observed in pups of dams given abatacept at doses up to 45 mg/ kg, representing 3-fold a human 10 mg/ kg exposure based on AUC.
In a separate pre- and post-natal development study in rats, body weights were lower for male pups following maternal administration at the high dose.
In a pre- and postnatal development study in rats, exposures far above the human exposure at the recommended dose did not harm the developing embryo or affect offspring growth and development. .
In a pre- and postnatal development study in rats, effects on pre- and post-natal development were seen at an exposure below the MRHD.
In a pre- and postnatal development study in rats, limited changes in immune function were observed at 19-fold a human 10 mg/kg dose based on AUC(see section 5.3).
In a pre- and post-natal development study, a slightly prolonged gestation period, reduced number of implantation sites, and reduced number of pups delivered were observed.
In the rat pre- and postnatal development study, a decrease in pup survival occurred between birth and postnatal day 21 at doses of 60 mg/kg/day or higher(5 times the expected human clinical exposure).
In the rat peri- and post-natal development study with tafamidis, decreased pup survival and reduced pup weights were noted following maternal treatment during pregnancy and lactation at doses of 15 and 30 mg/kg.
In the peri-post natal development study, high doses of histamine dihydrochloride caused maternal toxicity, and the offspring showed toxicity during lactation(fewer live pups at day 21 compared to lactation at day 4) but not after weaning.
In the pre- and post-natal development study in rats, exposure to rimonabant in utero and via lactation produced no alterations on learning or memory, but equivocal effects on motor activity and auditory startle response were observed in the pups as a result of rimonabant exposure.
In a pre- and postnatal development study with abatacept in rats, no undesirable effects were observed in pups of dams given abatacept at doses up to 45 mg/kg, representing 3-fold a human 10 mg/kg exposure based on AUC.
In the pre and postnatal development study in rats at exposures lower than those obtained in humans with therapeutic doses, voriconazole prolonged the duration of gestation and labour and produced dystocia with consequent maternal mortality and reduced perinatal survival of pups.